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Research on the natural history of hypertension has empha-
sized that its early stages typically involve a hyperkinetic 
circulatory state, characterized hemodynamically by ele-
vated cardiac output; with the progression of hypertensive 
disease, this hemodynamic profile ultimately transitions 
into elevated systemic vascular resistance (SVR).1 However, 
among African Americans, for whom hypertension is more 
prevalent than Caucasians and other ethnic groups and is 
associated with greater target organ damage, the hemody-
namic profile may be characterized by elevated SVR from 
the onset.2–4 Several studies have shown that even at similar 
levels of blood pressure (BP), SVR is greater among African 
Americans compared to Caucasians.5,6 African Americans 
also exhibit a propensity to vasoconstrictive responses to 
a wide range of environmental, physical, and psychosocial 
stressors, which may further contribute to the progression of 
hypertension and its adverse manifestations.5–9
The physiological basis for elevated SVR in the early stages 
of hypertension in African Americans is not well understood. 
Impaired vascular function is implicated as the predominant 
mechanism underlying the high rates of cardiovascular dis-
ease in African Americans.10 There is some evidence that 
blunted beta-adrenergic receptor vasodilator activity and 
heightened vascular alpha-adrenergic receptor sensitivity 
may be contributing factors.8,11–13 Impaired endothelial vas-
odilator function also may contribute to increased SVR in 
African Americans.14–17 Vascular hypertrophy, characterized 
by alterations (i.e., thickening) of the medial layer of the vas-
cular wall, is another potential etiology of an elevated SVR 
that typically emerges with the progression of hypertension 
but may also occur in its early stages.18,19 Evidence from 
studies in normotensive samples indicates that in addition to 
elevated SVR, African Americans also tend to exhibit struc-
tural microvascular differences, including greater wall thick-
ness and a narrower lumen diameter, compared to Whites.6 
Minimal forearm vascular resistance (MFVR), obtained 
using venous occlusion plethysmography, is a measure of 
the structural component of vascular resistance.20 Previous 
research has shown MFVR to be highly correlated (i.e., r 
≈ 0.70) with small artery media:lumen ratio,21 and other 
research has conceptualized MFVR as a surrogate index 
of vascular hypertrophy.22–25 Given that even small differ-
ences in vascular structure may have significant functional 
consequences,19,26 the purpose of the present study was to 
examine the association between SVR and a noninvasive 
marker of vascular hypertrophy and to determine whether 
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BACKGROUND
Hypertension in African Americans is characterized by greater systemic 
vascular resistance (SVR) compared with Caucasian Americans, but the 
responsible mechanisms are not known. The present study sought to 
determine if peripheral vascular hypertrophy is a potential mechanism 
contributing to elevated SVR in African Americans with high blood 
pressure (BP).
METHODS
In a biracial sample of 80 men and women between the ages of 25 and 
45 years, with clinic BP in the range 130/85–160/99 mm Hg, we assessed 
cardiac output and SVR, in addition to BP. Minimum forearm vascular 
resistance (MFVR), a marker of vascular hypertrophy, also was assessed.
RESULTS
SVR was elevated in African Americans compared with Caucasians 
(P  <  0.001). Regression models indicated that age, body mass 
index, 24-hour diastolic BP, and ethnicity were significant pre-
dictors of SVR. There was also a significant interaction between 
ethnicity and MFVR in explaining SVR in the study sample. In 
particular, there was a significant positive association between 
MFVR and SVR among African Americans (P = 0.002), whereas the 
association was inverse and not statistically significant among 
Caucasians (P = 0.601).
CONCLUSION
Hypertrophy of the systemic microvasculature may contribute to the 
elevated SVR that is characteristic of the early stages of hypertension in 
African American compared with Caucasians.
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Subjects were 80 men and women between the ages of 25 
and 45  years who participated in the Duke Biobehavioral 
Investigation of Hypertension (BIOH) study. Details of the 
study and primary results were published previously.27 The 
present study included individuals with untreated clinic BP 
in the range 130–160/85–99 mm Hg. The study protocol and 
all procedures were approved by Duke University Medical 
Center Institutional Review Board. Written informed con-
sent was obtained from all subjects prior to participation.
BP and hemodynamics
Clinic BPs were taken on 3 separate visits, each approxi-
mately 1 week apart. On each visit, 3 seated BP readings 
were taken, each 2 minutes apart, using an appropriate-
sized occlusion cuff, mercury column sphygmomanometer, 
and stethoscope. The systolic BP was recorded coincident 
with the first occurrence of Korotkoff sounds (phase I), 
and diastolic BP (DBP) with their disappearance (phase V). 
Hemodynamic measurements were made between 9:00 am 
and noon.
Cardiac output (CO) was estimated using impedance 
cardiography in accordance with published guidelines.28 
Impedance cardiography signals were recorded via a 
Minnesota Impedance Cardiograph (Model HIC-1, Bio-
Impedance Technology, Chapel Hill, NC) using a tetrapo-
lar band-electrode configuration. The recording electrode 
bands were positioned around the base of the neck and 
around the thorax over the xiphisternal junction. The cur-
rent electrode bands were positioned to encompass the neck 
and thorax, at least 3 cm away from each of the recording 
electrodes. The electrocardiogram was recorded from the 
Minnesota Impedance Cardiograph using disposable elec-
trocardiogram electrodes. The basal thoracic impedance 
(Zo), the first derivative of the pulsatile impedance (dZ/dt) 
and the electrocardiogram waveforms were processed using 
specialized ensemble-averaging software (COP, BIT), which 
was used to derive stroke volume using the Kubicek equa-
tion.28 To account for potential sex and ethnic differences in 
body size, CO and SVR were indexed by body surface area.
Ambulatory BP was also assessed during a typical work-
day for all participants. The AccuTracker II ABP Monitor 
(Suntech AccuTracker II), an auscultatory, noninvasive 
device, was worn for approximately 24 hours, usually start-
ing between 8:00 am and 10:00 am until the same time the 
following morning. The device was programmed to take 
4 BP measurements per hour at random intervals during 
the day and to take 2 BP readings per hour during sleeping 
hours. All BP readings were reviewed and artifactual read-
ings were deleted following criteria previously described.27 
Mean 24-hour systolic BP and DBP values were computed 
based on all valid readings obtained during waking hours 
and during nighttime sleep.
Minimum forearm vascular resistance
Evidence of vascular hypertrophy was assessed according 
to MFVR, calculated from measurements of BP and forearm 
blood flow during reactive hyperemia, as described previ-
ously.29 Forearm blood flow was measured in the left arm by 
mercury-in-silastic strain gauge using a Hokanson (Issaquah, 
WA) plethysmograph and rapid cuff inflator. With the subject 
reclining, the left forearm was suspended at the wrist and elbow 
slightly above heart level. An occlusion cuff was applied to the 
upper arm and a pediatric cuff was applied at the wrist. A mer-
cury-in-silastic strain gauge encircled the forearm approxi-
mately 5 cm distal to the antecubital crease and was coupled 
to an electronically calibrated plethysmograph. To produce 
forearm ischemia, the upper occlusion cuff was inflated to a 
suprasystolic pressure (200 mm Hg) for 10 minutes, during 
which time the subject was instructed to contract the hand for 
5 seconds of every 30-second interval. The pediatric wrist cuff 
was inflated to a suprasystolic pressure 1 minute before and 
during blood flow measurements in order to arrest circulation 
to the hand. Beginning 10 seconds after the release of arterial 
occlusion, the upper arm occlusion cuff was rapidly inflated 
to 40 mm Hg and deflated in l0-second cycles. BP was meas-
ured simultaneously in the right arm. Forearm blood flow in 
ml/100 ml forearm volume/min was determined by averaging 
the results from 3 plethysmographic curves during the 40–50 
seconds immediately after ischemia. Mean arterial pressure 
was calculated as DBP + 1/3 pulse pressure. MFVR was calcu-
lated as mean arterial pressure/forearm blood flow.
Data analysis
Analysis of variance and chi-square tests were imple-
mented to document any differences in demographic and 
hemodynamic characteristics between African American and 
Caucasian subjects. Correlational analyses were used to assess 
the strength of associations among MFVR, demographics, 
clinic BP, and hemodynamic variables. Hierarchical regres-
sions models were implemented to assess the association 
between SVR and MFVR, after controlling for potential con-
founds. All analyses were performed using the SAS (Cary, NC) 
software system; significance was set at P < 0.05 for all tests.
RESULTS
Demographic, anthropometric, and hemodynamic 
characteristics
The 80 subjects included 41 African Americans (22 
females; 19 males) and 39 Caucasians (10 females; 29 
males), with a mean age of 35 ± 6  years and an average 
screening BP of 138 ± 11/89 ± 9 mm Hg. Characteristics of 
the African American and Caucasian subjects are summa-
rized in Table 1. There were no ethnic differences in body 
surface area or ambulatory BP. Caucasian subjects were 
younger, on average, and had greater stoke volume and car-
diac index compared to African Americans, and body mass 
index (BMI) and clinic BP were marginally higher in African 
Americans. Despite similar BPs, African Americans exhib-
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Correlations with SVR
SVR was positively correlated with age (r = 0.32, P ≤ 0.01), 
BMI (r = 0.35, P ≤ 0.01), clinic DBP (r = 0.34, P ≤ 0.01), and 
ambulatory DBP (r = 0.31, P ≤ 0.01) and inversely associated 
with stroke volume index (r = −0.70, P ≤ 0.001) and cardiac 
index (r = −0.89, P ≤ 0.001). MFVR was inversely correlated 
with sex (r = −0.50, P ≤ 0.001). MFVR was positively asso-
ciated with older age (r = 0.22, P ≤ 0.05), clinic systolic BP 
(r = 0.27, P ≤ 0.05), and SVR (r = 0.23, P ≤ 0.05). Both SVR 
(r = 0.43, P ≤ 0.001) and MFVR (r = 0.33, P ≤ 0.01) were sig-
nificantly correlated with ethnicity indicating higher values 
in African Americans.
Multivariate associations with SVR
To further examine the association between SVR and 
MFVR, a series of hierarchical regression models were 
conducted (see Table  2). In model 1, which included age, 
sex, and ethnicity, age (b = 0.25, P = 0.017) and ethnicity 
(b = 0.42, P ≤ 0.001) were significant predictors of SVR. BMI 
and ambulatory BP were added in model 2, with both BMI 
(b = 0.30, P = 0.002) and 24-hour DBP (b = 0.37, P = 0.003) 
emerging as the only additional significant predictors. 
Model 3 added MFVR and the MFVR × ethnicity interac-
tion. Additionally, we tested for potential interactions of sex 
with ethnicity and/or MFVR by including sex × ethnicity and 
MFVR × sex cross-product terms in model 3. As depicted in 
Table 2, the effects of BMI and 24-hour DBP remained sig-
nificant; however, the effect for ethnicity was fully attenu-
ated with the inclusion of MFVR and the interaction terms. 
Neither the sex × ethnicity (b = 0.29, P = 0.13) nor the sex 
× MFVR interaction term (b = −0.51, P = 0.08) were sig-
nificant; however, the MFVR × ethnicity interaction was 
significant (b = 0.93, P = 0.023). As depicted in Figure 1, the 
association between SVR and MFVR differed as a function 
Table 1. Demographic characteristics and hemodynamics in African American and Caucasian subjects
African American (n = 41) Caucasian (n = 39) P value
Age (years) 36 ± 6 33 ± 6 0.033
Sex (% female) 56 26 0.009
Body mass index (kg/m2) 27.9 ± 4 26.2 ± 3.2 0.022
Body surface area (m2) 1.97 ± 0.20 1.97 ± 0.19 0.934
Clinic systolic blood pressure (mm Hg) 140 ± 13 136 ± 9 0.093
Clinic diastolic blood pressure (mm Hg) 91 ± 10 87 ± 7 0.018
24-hour systolic blood pressure (mm Hg) 133 ± 11 131 ± 8 0.324
24-hour diastolic blood pressure (mm Hg) 83 ± 7 82 ± 5 0.239
Heart rate (bpm) 67 ± 11 71 ± 12 0.129
Stroke volume index (ml/m2) 42 ± 11 51 ± 16 0.007
Cardiac index (l/min/m2) 2.7 ± 0.6 3.5 ± 0.8 <0.001
Systemic vascular resistance index (dyne-s-cm-5/m2) 2,853 ± 662 2,263 ± 566 <0.001
Minimum forearm vascular resistance 3.72 ± 1.4 2.88 ± 1.05 0.004
Table 2. Hierarchical regression model predicting systemic vascular resistance (N = 80)
Model 1 Model 2 Model 3
Estimate (β) P value Estimate (β) P value Estimate (β) P value
Age 0.25 0.017 0.22 0.03 0.13 0.15
Sex 0.09 0.40 0.06 0.51 0.40 0.27
Ethnicity 0.42 <0.001 0.34 0.001 −0.53 0.20
BMI 0.30 0.002 0.24 0.009
SBP24 −0.21 0.09 −0.22 0.06
DBP24 0.37 0.003 0.36 0.003
MFVR −0.13 0.60
Sex × ethnicity 0.29 0.13
MFVR × sex −0.51 0.08
MFVR × ethnicity 0.93 0.023
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of ethnicity. Whereas increasing MFVR was inversely asso-
ciated with SVR among Caucasians, for African Americans, 
greater SVR was associated with higher MFVR.
In order to ascertain whether the findings described above 
held for participants with hypertension that was defined 
rigorously, we repeated the multivariate analyses in a sub-
group restricted to those participants with average daytime 
ambulatory BP ≥135/85 mm Hg. As depicted in Table 3, the 
ethnicity × MFVR interaction remains significant (b = 1.33, 
P = 0.042) in this hypertensive subsample.
DISCUSSION
We observed that MFVR was differentially associated with 
resting SVR in African American and Caucasian adults with 
elevated BPs, independent of the influence of age, sex, and 
BMI. Specifically, we found that MFVR was positively asso-
ciated with SVR among African Americans; however, this 
pattern was inverse and not significant among Caucasians. 
Importantly, the present results support prior hypothesis 
that greater SVR among African Americans may be due to 
early structural changes in the peripheral vasculature.11,12,29
Although elevated SVR is typically associated with a more 
advanced hypertensive state,1 greater vascular resistance 
among African Americans develops early in life and irrespec-
tive of hypertensive status.6,30 Studies of cardiovascular reac-
tivity to behavioral challenges have demonstrated not only 
greater resting SVR among young, normotensive African 
Americans compared to Caucasians, but also a greater SVR 
response to the cold pressor and other laboratory-based 
stressors.3,30 In accord with previous work,30 our findings also 
raise the possibility that high SVR among African Americans 
Table 3. Hierarchical regression model predicting systemic vascular resistance in hypertensive participants (N = 59)
Model 1 Model 2 Model 3
Estimate (β) P value Estimate (β) P value Estimate (β) P value
Age 0.37 0.006 0.38 <0.001 0.27 0.03
Sex 0.11 0.43 0.03 0.79 −0.68 0.27
Ethnicity 0.34 0.01 0.18 0.13 −1.35 0.05
BMI 0.39 0.001 0.33 0.007
SBP24 −0.12 0.32 −0.15 0.19
DBP24 0.32 0.006 0.35 0.004
MFVR −0.44 0.22
Sex × ethnicity 1.45 0.054
MFVR × sex 0.33 0.50
MFVR × ethnicity 1.33 0.042
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; MFVR, minimum forearm vascular resistance; SBP, systolic blood 
pressure.
Figure 1. Model-estimated change in systemic vascular resistance index (SVRI) for 1 SD change in minimal forearm vascular resistance (MFVR) in African 
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may not be preceded by the typical “hyperkinetic” pattern 
of elevated CO. Alternatively, the transition from high CO 
to a state of high vascular resistance may occur at a much 
younger age among African Americans, which may further 
enhance the risk for early vascular remodeling.
Although BPs were comparable among African 
Americans and Caucasians in our study, both SVR and 
MFVR were significantly higher in African Americans. 
Increased MFVR is considered an early marker of hyperten-
sion-related remodeling of the small arteries and vascular 
damage.14,31,32 Notably, Eftekhari et al. examined hemody-
namic differences between patients with either stage 1 or 
stage 2 hypertension and a normotensive control group. 
Compared to controls, both hypertensive groups exhibited 
greater SVR and MFVR. Importantly, while elevations in 
24-hour BP were up to 28% greater among the hyperten-
sives relative to controls, the degree of elevation in MFVR 
was 58% and 87% greater for stage 1 and stage 2 groups, 
respectively.31 As these authors suggest, for those in the 
early stages of hypertension, the degree of BP elevation does 
not necessarily indicate the level of underlying microvascu-
lar impairment.
While it is apparent that vascular resistance more strongly 
influences BP among African Americans, the origins of this 
pattern remain unclear. There is evidence that genetic factors 
may play a role in elevated vascular resistance.33 For example, 
a positive family history of hypertension has been related to 
both greater SVR and MFVR.14,34 In addition, twin research 
has shown that the relative contribution of genetic factors 
to resting SVR may be greater among African Americans 
compared to Caucasians.33 There is also some indication 
that genetic factors may have a larger influence on SVR 
during stress among African American males, compared to 
females.35 Other work has shown that stress-related changes 
in MFVR may be similar in African American males, irre-
spective of family history of hypertension.36
Despite African Americans in our sample being slightly 
older and having a modestly greater BMI than Caucasians, 
analyses indicated that these factors did not account for our 
observed racial differences in MFVR. Nonetheless, future 
research on ethnic differences in vascular resistance and 
hypertrophy should more closely examine the influence 
of these and other nongenetic factors. For instance, it has 
been suggested that the cumulative impact of several fac-
tors including more frequent exposure to environmental 
and psychosocial stressors, contributes to accelerated bio-
logical aging in African Americans.37 Compatible with this 
view, MFVR values among African Americans in our sam-
ple were consistent with previously reported levels among 
an older European cohort with established hypertension.31 
As other work has shown, there are a number of complex 
pathways through which greater BMI may influence micro-
vascular function,10 and there is some evidence that obesity 
is associated with vascular hypertrophy in young African 
Americans. Notably, previous research found that obese 
African American adolescents exhibited greater MFVR com-
pared to nonobese African American and obese Caucasian 
adolescents.38 Although age and ethnicity are nonmodifiable 
factors, there is prospective evidence that vascular hyper-
trophy can be effectively reversed using antihypertensive 
medications.39 These findings suggest the possibility that 
monitoring changes in small artery structure may prove use-
ful in determining treatment efficacy in the management of 
hypertension in African Americans.
Limitations
Because this was a cross-sectional study in which assess-
ments of SVR and MFVR were obtained concurrently, we 
are unable to address the cause–effect relationship between 
them. This temporal distinction is important in determining 
whether structural microvascular changes should be regarded 
as a risk factor or simply as a disease marker. We also did 
not examine the relationship between MFVR and SVR dur-
ing stress. Stress-induced changes in SVR have previously 
been linked to myocardial ischemia during stress.40 Although 
MFVR was found to be unrelated to SVR during stress in a 
previous study of Caucasians,41 our findings suggest that the 
MFVR relationship to stress SVR merits further investigation 
in African Americans. In the present study, SVR was derived 
from estimates of CO obtained via impedance cardiogra-
phy. Impedance cardiography is more widely accepted as a 
measure of change in CO than of absolute levels; however, 
in lieu of more advanced and/or invasive methods, and with 
adequate sample size, resting estimates have been considered 
acceptable.28 Our sample contained a larger proportion of 
males compared to females, so it is possible that sex differ-
ences may have at least partially accounted for our findings. 
However, we did not find sex to be a significant predictor of 
SVR index independently or interactively with ethnicity or 
MFVR. Nonetheless, future work should more closely exam-
ine interactions between ethnicity and sex in relation to SVR 
and vascular hypertrophy. Finally, based upon previous liter-
ature22–25 we interpreted increased MFVR to indicate greater 
vascular hypertrophy among African Americans compared 
to Whites; however, other potential mechanisms including 
differences in vascular contractility, adrenergic receptor sen-
sitivity, microvascular rarefaction, and nitric oxide bioavail-
ability may all contribute to elevated SVR.6,10,15,19,20
In conclusion, our observations suggest that the relation-
ship between SVR and MFVR is moderated by ethnicity 
among young to middle-aged adults with moderately elevated 
BP. Moreover, for African Americans with high BP, among 
whom elevated SVR is more common, the degree of SVR ele-
vation appears closely related to microvascular impairment. 
Contemporary perspectives conceptualize hypertension as 
a vascular disease and vascular dysfunction has been char-
acterized as the primary determinant of the excessive car-
diovascular disease burden faced by African Americans.10,20 
Consistent with these views, it is plausible that the greater 
prevalence of hypertension seen in African Americans may 
reflect a larger underlying pattern of vascular remodeling.
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